A carregar...

Retrospective practice review of treatment of metastatic non-small-cell lung cancer with second-line erlotinib

BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (egfr-tkis) and chemotherapy have both demonstrated efficacy in recurrent metastatic non-small-cell lung cancer (nsclc) following failure of first-line platinum-based chemotherapy. Although the 3 available therapeutic agents—doc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Melosky, B., Agulnik, J., Assi, H.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2601023/
https://ncbi.nlm.nih.gov/pubmed/19079629
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!